Open access · CC-BY
via OpenAlex
Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
Matilde Contardo, Roberta De Gioia, Delia Gagliardi, Giacomo P. Comi, Linda Ottoboni, Monica Nizzardo, Stefania Paola Corti
Biomedicines · 2022 · ▲ 14 citations
Abstract
In vivo cell reprogramming of glial cells offers a promising way to generate new neurons in the adult mammalian nervous system. This approach might compensate for neuronal loss occurring in neurological disorders, but clinically viable tools are needed to advance this strategy from bench to bedside. Recently published work has described the successful neuronal conversion of glial cells through the repression of a single gene, polypyrimidine tract-binding protein 1 (Ptbp1), which encodes a key RNA-binding protein. Newly converted neurons not only express correct markers but they also functionally integrate into endogenous brain circuits and modify disease symptoms in in vivo models of neurodegenerative diseases. However, doubts about the nature of “converted” neurons, in particular in vivo, have been raised, based on concerns about tracking reporter genes in converted cells. More robust lineage tracing is needed to draw definitive conclusions about the reliability of this strategy. In vivo reprogramming and the possibility of implementing it with approaches that could be translated into the clinic with antisense oligonucleotides targeting a single gene like Ptbp1 are hot topics. They warrant further investigation with stringent methods and criteria of evaluation for the ultimate treatment of neurological diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/biomedicines10020399
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Contardo, M., Gioia, R.D., Gagliardi, D., Comi, G.P., Ottoboni, L., Nizzardo, M., & Corti, S.P. (2022). Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines10020399
Vancouver
Contardo M, Gioia RD, Gagliardi D, Comi GP, Ottoboni L, Nizzardo M, et al. Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases. Biomedicines. 2022. doi:10.3390/biomedicines10020399.
BibTeX
@article{matilde2022Target,
title = {Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases},
author = {Matilde Contardo and Roberta De Gioia and Delia Gagliardi and Giacomo P. Comi and Linda Ottoboni and Monica Nizzardo and Stefania Paola Corti},
journal = {Biomedicines},
year = {2022},
doi = {10.3390/biomedicines10020399},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Reports 2020
Open access · CC-BY
In Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice
Annual Review of Genetics 2018
Open access · OA
Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases
Human Genetics 2023
Open access · CC-BY
Transcriptomic reprogramming for neuronal age reversal
Frontiers in Aging Neuroscience 2022
Open access · CC-BY
Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures
Frontiers in Neuroanatomy 2021
Open access · CC-BY
Organization of the Catecholaminergic System in the Short-Lived Fish Nothobranchius furzeri
Journal of Clinical Investigation 2010
Open access · OA